Published in J Neuroimmune Pharmacol on February 02, 2011
Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life (2012) 0.91
Abnormal corpus callosum in neonates after hypoxic-ischemic injury. Pediatr Radiol (2011) 0.84
Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol (2014) 0.83
HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling. Exp Cell Res (2014) 0.82
Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One (2014) 0.82
The Role of HIV Infection in Neurologic Injury. Brain Sci (2017) 0.75
EXPRESS: Oligodendrocytes in HIV-associated pain pathogenesis. Mol Pain (2016) 0.75
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders. Brain Sci (2016) 0.75
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature (2004) 17.56
The AIDS dementia complex: II. Neuropathology. Ann Neurol (1986) 5.61
Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature (2001) 5.60
A novel brain ATPase with properties expected for the fast axonal transport motor. Nature (1985) 5.30
Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature (1994) 3.87
HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science (1990) 3.41
Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A (1998) 3.18
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev (2005) 2.78
Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell (2000) 2.73
Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol (2001) 2.48
Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett (1993) 2.35
NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem (1996) 2.29
Axonal damage: a key predictor of outcome in human CNS diseases. Brain (2003) 2.27
Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol (1998) 2.21
Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (1988) 2.17
Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci (1998) 2.00
Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J Neurotrauma (1995) 1.77
Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A (1993) 1.75
Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron (1991) 1.73
CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A (2010) 1.62
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol (2009) 1.57
Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci (2002) 1.52
White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage (2009) 1.52
The neuropathology of adult HIV infection. Rev Neurol (Paris) (1998) 1.49
Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol (2000) 1.48
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol (1992) 1.23
Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv Immunol (1996) 1.23
Rodent models for HIV-1 infection and disease. Curr HIV Res (2003) 1.12
Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol (2002) 1.12
Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol (1997) 1.11
Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol (1997) 1.09
Is beta-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol (1996) 1.08
Human immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19 cases with combined use of in situ hybridization and immunocytochemistry. J Neuropathol Exp Neurol (1994) 1.06
Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol (1997) 1.06
Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol (1997) 1.02
Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res (1993) 0.98
gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience (1997) 0.98
Astrocyte associations with nodes of Ranvier: ultrastructural analysis of HRP-filled astrocytes in the mouse optic nerve. J Neurocytol (1994) 0.97
Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Neuroscience (1999) 0.93
The chemokine receptor CXCR4 and not the N-methyl-D-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells. J Neurosci Res (2004) 0.92
White matter changes in HIV-1 infected brains: a combined gross anatomical and ultrastructural morphometric investigation of the corpus callosum. Clin Neurol Neurosurg (2009) 0.90
Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor. Biochem Biophys Res Commun (2000) 0.86
Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices. J Neurosci Res (2006) 0.86
HIV-related demyelinating disease. Eur J Med (1993) 0.84
Calmodulin regulates fast axonal transport of squid axoplasm organelles. Brain Res Bull (1995) 0.83
Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture. Arch Virol (1994) 0.81
HIV-gp120 affects the functional activity of oligodendrocytes and their susceptibility to complement. J Neurosci Res (1997) 0.78
Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection. Virol J (2009) 0.77
Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol (2004) 1.61
HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr (2002) 1.46
Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol Cell Neurosci (2007) 1.44
Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest (2004) 1.42
Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma. Curr Med Res Opin (2003) 1.36
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entry. J Biol Chem (2006) 1.32
MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis (2010) 1.26
Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J Immunol (2008) 1.23
CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. PLoS One (2009) 1.21
Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J Neurosci (2005) 1.16
Differentiation of embryonic stem cells into retinal neurons. Biochem Biophys Res Commun (2002) 1.12
Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci (2002) 1.08
Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J Neurosci (2004) 1.06
Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol (2005) 1.04
Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression. J Biol Chem (2012) 1.03
Acetyl-L-carnitine protects neuronal function from alcohol-induced oxidative damage in the brain. Free Radic Biol Med (2010) 1.02
FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci U S A (2011) 1.00
Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One (2008) 0.99
Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. J Neurochem (2003) 0.98
Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem (2010) 0.98
Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation. J Neurochem (2007) 0.98
Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration. J Neuroimmune Pharmacol (2008) 0.98
Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res (2008) 0.98
Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. Life Sci (2009) 0.97
Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. J Biol Chem (2010) 0.94
HIV-1gp120 induces neuronal apoptosis through enhancement of 4-aminopyridine-senstive outward K+ currents. PLoS One (2011) 0.94
HIV-1-infected astrocytes and the microglial proteome. J Neuroimmune Pharmacol (2008) 0.92
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol (2003) 0.91
4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis. J Neuroimmune Pharmacol (2009) 0.89
HIV-1 gp120 enhances giant depolarizing potentials via chemokine receptor CXCR4 in neonatal rat hippocampus. Eur J Neurosci (2006) 0.89
High fatty acids modulate P2X(7) expression and IL-6 release via the p38 MAPK pathway in PC12 cells. Brain Res Bull (2013) 0.87
Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis. J Neuroimmunol (2010) 0.87
Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2009) 0.87
Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia (2008) 0.87
Unraveling a masticatory - oculomotor neural pathway in rat: Implications for a pathophysiological neural circuit in human? Int J Physiol Pathophysiol Pharmacol (2011) 0.86
Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices. J Neurosci Res (2006) 0.86
HIV-1 Tat protein increases microglial outward K(+) current and resultant neurotoxic activity. PLoS One (2013) 0.84
HIV-1 gp120 enhances outward potassium current via CXCR4 and cAMP-dependent protein kinase A signaling in cultured rat microglia. Glia (2011) 0.83
Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders. J Neuroimmune Pharmacol (2008) 0.83
Improvement in quality of life with omalizumab in patients with severe allergic asthma. Curr Med Res Opin (2006) 0.82
Modulation of network-driven, GABA-mediated giant depolarizing potentials by SDF-1alpha in the developing hippocampus. Dev Neurosci (2007) 0.82
Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration. Biochem Biophys Res Commun (2010) 0.82
Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008. J Neuroimmune Pharmacol (2009) 0.82
Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity. J Proteome Res (2013) 0.81
Enhancement of neuronal outward delayed rectifier K+ current by human monocyte-derived macrophages. Glia (2009) 0.81
Adult ciliary epithelial stem cells generate functional neurons and differentiate into both early and late born retinal neurons under non-cell autonomous influences. BMC Neurosci (2013) 0.81
Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology. J Neuroimmune Pharmacol (2013) 0.80
Peripheral nerve induces macrophage neurotrophic activities: regulation of neuronal process outgrowth, intracellular signaling and synaptic function. J Neuroimmunol (2003) 0.80
Reduction of brain mitochondrial β-oxidation impairs complex I and V in chronic alcohol intake: the underlying mechanism for neurodegeneration. PLoS One (2013) 0.79
N-methyl-D-aspartate receptor-mediated axonal injury in adult rat corpus callosum. J Neurosci Res (2012) 0.79
Voltage-gated potassium channel modulation of neurotoxic activity in human immunodeficiency virus type-1(HIV-1)-infected macrophages. J Neuroimmune Pharmacol (2007) 0.79
Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels. Retrovirology (Auckl) (2008) 0.78
CD4(+)CD25(-) effector T-cells inhibit hippocampal long-term potentiation in vitro. Eur J Neurosci (2007) 0.78
Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1. Mol Cell Neurosci (2013) 0.78
Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infection. Biomed Res Int (2012) 0.78
Battle of animal models. J Neuroimmune Pharmacol (2006) 0.77
Involvement of the 4-aminopyridine-sensitive transient A-type K+ current in macrophage-induced neuronal injury. Eur J Neurosci (2010) 0.77
Macrophage attenuation of neuronal excitability: implications for pathogenesis of neurodegenerative disorders. Glia (2008) 0.77
Expression profile of mitrogen-activated protein kinase (MAPK) signaling genes in the skeletal muscle & liver of rat with type 2 diabetes: role in disease pathology. Indian J Med Res (2014) 0.77
Differentiation of embryonic stem cells to retinal cells in vitro. Methods Mol Biol (2006) 0.76
Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine. Int J Physiol Pathophysiol Pharmacol (2013) 0.75
Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status. AIDS (2017) 0.75
Jaw muscle spindle afferents coordinate multiple orofacial motoneurons via common premotor neurons in rats: an electrophysiological and anatomical study. Brain Res (2012) 0.75
Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS (2017) 0.75
SNIP members in a recent international conference: World Summit of Antivirals. J Neuroimmune Pharmacol (2008) 0.75